Home Covid-19
The lung disease Covid-19, which is caused by the novel coronavirus known as SARS-CoV-2, has the world in its grip. GBN is bringing biobanks and researchers together to gain insights into the disease and develop treatments.
See here for information on handling biosamples as well as further literature.
From swabs to whole blood – these German biobanks are collecting SARS-CoV-2 samples.
09/20/2023
Insbesondere „junge“ Biobanken können mit dem Starterkit von dem geballten Wissen profitieren, das in der letzten Dekade von GBN/GBA erarbeitet wurde.
09/19/2023
Die Mitglieder des SEAB gratulierten German Biobank Node (GBN) und German Biobank Alliance (GBA) zu einer dynamischen Entwicklung.
09/08/2023
In order to facilitate the exchange and sharing of biospecimens and associated data, GBN has developed an MTA template for biobanks.
germanbiobanknode@charite.de
Tel. +49. 30. 450 536 347
Fax +49. 30. 450 753 69 38
© 2023 All rights reserved.
